Literature DB >> 11120951

Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

A L Baltch1, R P Smith, M A Franke, W J Ritz, P B Michelsen, L H Bopp.   

Abstract

This study evaluates the effects of cytokines, used singly and in combination, on the microbicidal activity of human monocyte-derived macrophages (MDM) against intracellular Candida albicans in the presence and absence of fluconazole. In the absence of fluconazole, the addition of tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), gamma interferon (IFN-gamma), or IL-4 had no effect on the growth of C. albicans. In contrast, the addition of granulocyte-macrophage colony-stimulating factor (GM-CSF) resulted in decreased growth (P < 0.05), while the addition of IL-10 resulted in increased growth (P < 0.01). In the presence of fluconazole, only the addition of IFN-gamma resulted in an increase in the growth of C. albicans. In the presence or absence of fluconazole, all cytokine combinations except IFN-gamma plus GM-CSF caused significant decreases in growth (P < 0.01). IL-10 and IL-4 did not influence the activity of TNF-alpha or IL-1beta. In the absence or presence of C. albicans the addition of fluconazole, all of the cytokines studied, and combinations of fluconazole and selected cytokines caused increases in nitric oxide (NO) production (P < 0.01). Similar observations were made for superoxide (O(2)(-)) only in the presence of C. albicans. The greatest concentrations of NO and O(2)(-) were produced when C. albicans alone was present in the assays. Our results demonstrate that in the presence of low concentrations of fluconazole (0.1 times the MIC), selected cytokines and their combinations significantly increase the microbicidal activity of MDM against intracellular C. albicans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120951      PMCID: PMC90246          DOI: 10.1128/AAC.45.1.96-104.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  59 in total

Review 1.  The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.

Authors:  V T Andriole
Journal:  J Antimicrob Chemother       Date:  1999-08       Impact factor: 5.790

2.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Different events involved in the induction of macrophage tumor necrosis factor by Candida albicans and lipopolysaccharide.

Authors:  E Blasi; L Pitzurra; M Puliti; R Mazzolla; R Barluzzi; S Saleppico; F Bistoni
Journal:  Cell Immunol       Date:  1994-09       Impact factor: 4.868

4.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

5.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.

Authors:  M Schneemann; G Schoedon; S Hofer; N Blau; L Guerrero; A Schaffner
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

Review 6.  Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  T C Jones
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

7.  A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Authors:  J M Rowe; J W Andersen; J J Mazza; J M Bennett; E Paietta; F A Hayes; D Oette; P A Cassileth; E A Stadtmauer; P H Wiernik
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

8.  Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes.

Authors:  R D Diamond; E Huber; C C Haudenschild
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

9.  Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.

Authors:  A Louie; A L Baltch; R P Smith; M A Franke; W J Ritz; J K Singh; M A Gordon
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 10.  A comparative review of colony-stimulating factors.

Authors:  J Nemunaitis
Journal:  Drugs       Date:  1997-11       Impact factor: 11.431

View more
  6 in total

1.  Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.

Authors:  A Marcil; D Harcus; D Y Thomas; M Whiteway
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 2.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

3.  Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.

Authors:  Andriani C Patera; Frederick Menzel; Craig Jackson; Joan K Brieland; Judy Halpern; Roberta Hare; Anthony Cacciapuoti; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis.

Authors:  Bryan D Bryson; Tracy R Rosebrock; Fikadu G Tafesse; Christopher Y Itoh; Armel Nibasumba; Gregory H Babunovic; Bjorn Corleis; Constance Martin; Caroline Keegan; Priscila Andrade; Susan Realegeno; Douglas Kwon; Robert L Modlin; Sarah M Fortune
Journal:  Nat Commun       Date:  2019-05-27       Impact factor: 14.919

5.  The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis.

Authors:  Ayse Kalkanci; Semra Kustimur
Journal:  Yale J Biol Med       Date:  2002 Sep-Dec

6.  Proinflammatory profile of in vitro monocytes in the ageing is affected by lymphocytes presence.

Authors:  Karen Henriette Pinke; Bruno Calzavara; Patricia Freitas Faria; Magda Paula Pereira do Nascimento; James Venturini; Vanessa Soares Lara
Journal:  Immun Ageing       Date:  2013-06-08       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.